Surviving life-threatening MDMA (3,4-methylenedioxymethamphetamine, ecstasy) toxicity caused by ritonavir (RTV)

被引：9
|
作者：
Papaseit, Esther [1 ,4 ]
Vazquez, Antonia [2 ]
Perez-Mana, Clara [1 ,4 ]
Pujadas, Mitona [1 ]
de la Torre, Rafael [1 ,3 ]
Farre, Magi [1 ,4 ]
Nolla, Joan [2 ,3 ]
机构：
[1] IMIM Hosp del Mar Res Inst, Human Pharmacol & Clin Neurosci Res Grp, Neurosci Res Program, Barcelona, Spain
[2] Hosp del Mar, Intens Care Unit, Barcelona, Spain
[3] Dept Expt & Hlth Sci CEXS UPF, Barcelona, Spain
[4] UAB, Dept Pharmacol Therapeut & Toxicol, Barcelona, Spain
来源：
INTENSIVE CARE MEDICINE | 2012年 / 38卷 / 07期
关键词：
HUMANS;
D O I：
10.1007/s00134-012-2537-9
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1239 / 1240
页数：2
相关论文
共 50 条
  • [1] Surviving life-threatening MDMA (3,4-methylenedioxymethamphetamine, ecstasy) toxicity caused by ritonavir (RTV)
    Esther Papaseit
    Antonia Vázquez
    Clara Pérez-Mañá
    Mitona Pujadas
    Rafael de la Torre
    Magí Farré
    Joan Nolla
    [J]. Intensive Care Medicine, 2012, 38 : 1239 - 1240
  • [2] Ecstasy: 3,4-methylenedioxymethamphetamine (MDMA)
    Morimoto, BH
    Lovell, S
    Kahr, B
    [J]. ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1998, 54 : 229 - 231
  • [3] A review on the mitochondrial toxicity of "ecstasy" (3,4-methylenedioxymethamphetamine, MDMA)
    Capela, Joao Paulo
    Carvalho, Felix Dias
    [J]. CURRENT RESEARCH IN TOXICOLOGY, 2022, 3
  • [4] Life-threatening intoxications related to persistent MDMA (3,4-methylenedioxymethamphetamine) concentrations
    Di Trapani, Laura
    Eiden, Celine
    Mathieu, Olivier
    Diot, Caroline
    Donnadieu-Rigole, Helene
    Peyriere, Helene
    [J]. TOXICOLOGIE ANALYTIQUE ET CLINIQUE, 2018, 30 (01) : 80 - 83
  • [5] The Agony of Ecstasy: MDMA (3,4-Methylenedioxymethamphetamine) and the Kidney
    Campbell, Garland A.
    Rosner, Mitchell H.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (06): : 1852 - 1860
  • [6] NEUROCHEMISTRY AND NEUROTOXICITY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, ECSTASY)
    MCKENNA, DJ
    PEROUTKA, SJ
    [J]. JOURNAL OF NEUROCHEMISTRY, 1990, 54 (01) : 14 - 22
  • [7] Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy')
    McCann, UD
    Slate, SO
    Ricaurte, GA
    [J]. DRUG SAFETY, 1996, 15 (02) : 107 - 115
  • [8] The cardiovascular effects of ecstasy (3,4-methylenedioxymethamphetamine, MDMA)
    Lester, SJ
    Baggott, MJ
    Viloria, EM
    Welm, S
    Schiller, NB
    Mendelson, J
    Jones, RT
    Foster, E
    [J]. CIRCULATION, 1999, 100 (18) : 575 - 575
  • [9] 3,4-methylenedioxymethamphetamine (MDMA, or ''ecstasy'') and associated hypoglycemia
    Montgomery, H
    Myerson, S
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 1997, 15 (02): : 218 - 218
  • [10] 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment
    Logan, BK
    Couper, FJ
    [J]. JOURNAL OF FORENSIC SCIENCES, 2001, 46 (06) : 1426 - 1433
12345